‘Not time to give up’ on tau protein therapeutics, expert says

SEATTLE — Although successful tau therapeutics have not yet been identified, new insights into the protein’s biology may soon lead to treatments, according to a presenter at the 2022 American Academy of Neurology annual meeting.
“The general principle in tauopathies [is] that both the amount of inside tau and the anatomical location of the tau protein in autopsy is strongly correlated with the severity and also the clinical features of disease,” Adam J. Boxer, MD, PhD, Endowed Professor in Memory and Aging at the Weill Institute for Neurosciences at the University of

SEATTLE — Although successful tau therapeutics have not yet been identified, new insights into the protein’s biology may soon lead to treatments, according to a presenter at the 2022 American Academy of Neurology annual meeting.
“The general principle in tauopathies [is] that both the amount of inside tau and the anatomical location of the tau protein in autopsy is strongly correlated with the severity and also the clinical features of disease,” Adam J. Boxer, MD, PhD, Endowed Professor in Memory and Aging at the Weill Institute for Neurosciences at the University of